Buformin suppresses osteosarcoma via targeting AMPK signaling pathway.

Ding, Yan; Lv, Shiqiao; Li, Guangrun; Cui, Jinpeng; Chen, Yunzhen

Ding, Yan; Lv, Shiqiao; Li, Guangrun; Cui, Jinpeng; Chen, Yunzhen.

Afiliação

Ding Y; Department of Spine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, No. 107 West Wenhua Road, Jinan 250012, Shandong Province, China.
Lv S; Department of Orthopedics, Yantaishan Hospital, Yantai 264000, China.
Li G; Department of Orthopedics, Yantaishan Hospital, Yantai 264000, China.
Cui J; Department of Spine, Yantai Yuhuangding Hospital Affiliated to Medical College of Qingdao University, Yantai 264000, China.
Chen Y; Clinical Laboratory, Yantaishan Hospital, Yantai 264000, China.

Open Life Sci ; 15(1): 409-417, 2020.

Article em En | MEDLINE | ID: mdl-33817229

Palavras-chave

AMPK signal pathway; buformin; osteosarcoma; synergistic effect

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Open Life Sci Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google